相关实验视频

Updated: May 25, 2025

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.3K

突变特征对GIST中新辅助疗法的结果的影响

Mahmoud Mohammadi1, Evelyne Roets2, Roos F Bleckman3

  • 1Department of Medical Oncology, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Cancers
|February 26, 2025
PubMed
概括

新辅助剂伊马替尼在胃肠道 stromal 瘤 (GISTs) 中表现出不同的有效性,基于突变. 患有KIT-exon 11突变的患者在这种治疗中经历了更好的部分反应和更好的外科治疗结果.

关键词:
在治疗GIST时的突变特征.在GIST中使用新辅助剂伊马替尼布.

更多相关视频

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1000
A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.1K

相关概念视频

Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.7K